Effect of Polyamorphism on the Morphology, Dissolution, and Stability of Olaparib (original) (raw)
Related papers
Recent Technologies for Amorphization of Poorly Water-Soluble Drugs
Pharmaceutics
Amorphization technology has been the subject of continuous attention in the pharmaceutical industry, as a means to enhance the solubility of poorly water-soluble drugs. Being in a high energy state, amorphous formulations generally display significantly increased apparent solubility as compared to their crystalline counterparts, which may allow them to generate a supersaturated state in the gastrointestinal tract and in turn, improve the bioavailability. Conventionally, hydrophilic polymers have been used as carriers, in which the amorphous drugs were dispersed and stabilized to form polymeric amorphous solid dispersions. However, the technique had its limitations, some of which include the need for a large number of carriers, the tendency to recrystallize during storage, and the possibility of thermal decomposition of the drug during preparation. Therefore, emerging amorphization technologies have focused on the investigation of novel amorphous-stabilizing carriers and preparation...
Amorphous Solid Dispersion as Drug Delivery Vehicles in Cancer
Polymers
Cancer treatment has improved over the past decades, but a major challenge lies in drug formulation, specifically for oral administration. Most anticancer drugs have poor water solubility which can affect their bioavailability. This causes suboptimal pharmacokinetic performance, resulting in limited efficacy and safety when administered orally. As a result, it is essential to develop a strategy to modify the solubility of anticancer drugs in oral formulations to improve their efficacy and safety. A promising approach that can be implemented is amorphous solid dispersion (ASD) which can enhance the aqueous solubility and bioavailability of poorly water-soluble drugs. The addition of a polymer can cause stability in the formulations and maintain a high supersaturation in bulk medium. Therefore, this study aimed to summarize and elucidate the mechanisms and impact of an amorphous solid dispersion system on cancer therapy. To gather relevant information, a comprehensive search was condu...
2018
Out of many, one of the most promising strategies to improve the oral bioavailability of poorly water-soluble drugs is to develop amorphous solid dispersions. Reduction in drug particle size improves drug wettability and oral bioavailability significantly. Poorly soluble drugs are benefited by formulation approaches that overcome the issue of poor solubility and dissolution rate limited bioavailability. As Gibbs free energy is higher, the solubility of amorphous compounds is much greater than the more stable crystalline form. Moreover, amorphous forms are kinetically trapped high energy disordered materials that lack the periodicity of crystals but behave mechanically as solids. Lipophilic drugs, especially those belonging to the biopharmaceutics classification system (BCS) class II and IV, dissolve at a slower rate, leading to incomplete release of drug from the dosage form, poor oral bioavailability, increased food effect, and high inter-patient variability. Hence, to improve the ...